JLPC(SH:600513) Shang Hai Zheng Quan Bao·2025-09-15 19:41Group 1 - The core viewpoint of the announcement is the successful convening of the second extraordinary general meeting of shareholders for Jiangsu Lianhuan Pharmaceutical Co., Ltd. on September 15, 2025, with all resolutions passed without any objections [2][4][6] - The meeting was held at the company's conference room in Yangzhou and was presided over by the chairman, Qian Zhenhua, using a combination of on-site and online voting methods, complying with relevant laws and regulations [2][3][4] - All current directors and supervisors attended the meeting, ensuring full representation of the board [3] Group 2 - Multiple resolutions were passed, including the proposal to increase designated information disclosure media, cancel the supervisory board, and amend the company's articles of association [4][5] - Other resolutions included amendments to the rules for shareholder meetings, board meetings, and the selection of accounting firms, all of which were approved [5][6] - The meeting was legally witnessed by Beijing Zhonglun (Chengdu) Law Firm, confirming that the procedures and voting results were valid and in accordance with legal requirements [7]